Eran Elhanani, CEO of BullPerks, a top decentralized VC and multichain launchpad, signalled his confidence in the project, ...

54% of product managers are unable to support marketers in experimenting with onboarding flows, banner placement, homepage ...

By identifying the ideal manufacturing conditions, machine learning reduces the need for expensive and time-consuming ...

ABP-671 is a class 1 innovative chemotherapeutic drug for the treatment of gout and hyperuricemia, currently in Phase 2b/3 clinical trials for gout in China and overseas. The Product reduces renal ...

MHI Receives Order to Supply 24 MOX Fuel Assemblies for Unit 3 of Ikata Nuclear Power Station, Shikoku Electric Power Co. Inc ...

Through this collaboration, Fujitsu will combine its expertise in systems integration and its Fujitsu Uvance offering to solve societal issues with AWS’s cloud services and cloud-native architecture ...

Spritzer’s Head of Public Relations, Winnie Chin, accepting the Brand of the Year award under the national beverage ...

(MHI) has received an order from Taiwan High Speed Rail Corporation to install new equipment and modify existing equipment ...

(HQ: Chigasaki, Kanagawa) has started accepting orders for the ENTRON-EXX, a new multi-chamber deposition system for ...

The number of UC patients in China is projected to double from 2019 to 2030 to approximately one million, highlighting the urgent need for novel treatments." said Rogers Yongqing Luo, Chief Executive ...

SHANGHAI, Nov 30, 2024 - (ACN Newswire) - Hua Medicine (the “Company”, HKEx stock code: 2552) announced today that the Company has successfully completed its SENSITIZE study on the mechanism by which ...

SHANGHAI, Nov 30, 2024 - (ACN Newswire) - Hua Medicine (the “Company”, HKEx stock code: 2552) announced today that the Company has successfully completed a Phase I clinical trial on its 2nd generation ...